logo
AI Icon𝛼SK or Search
ENTITY

Myriad Genetics (MYGN US)

13
Analysis
Health Care • United States
Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
more
Company Event • 04 Jun 2026 22:00 • Upcoming
Add To Calendar

AGM 2026

Company Event • 10 Jun 2026 20:40 • Upcoming
Add To Calendar

Goldman Sachs 47th Annual Global Healthcare Conference 2026

Company Event • 05 Aug 2026 04:30 • Upcoming
Add To Calendar

Q2 2026

Company Event • 06 May 2026 04:30 • Latest

Q1 2026

Company Event • 14 Apr 2026 20:00 • Upcoming
Add To Calendar

Proxy filing

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1

x